NAMPT and cancer: Altogether, the data suggest that whenever NAM is available, any NA-producing microorganisms such as various bacteria species (for instance gut microbiota), may strongly reduce the efficacy of NAMPT inhibitors by activating NAD+ production through the Preiss-Handler pathway in cancer cells.